Dr. Lawrence Schiff, MD

NPI: 1326075185
Total Payments
$1,071
2024 Payments
$98.26
Companies
14
Transactions
32
Medicare Patients
672
Medicare Billing
$72,694

Payment Breakdown by Category

Food & Beverage$1,071 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $1,071 32 100.0%

Top Paying Companies

Company Total Records Latest Year
Allergan Inc. $375.53 10 $0 (2018)
Neurelis, Inc. $125.00 1 $0 (2021)
Janssen Pharmaceuticals, Inc $116.11 6 $0 (2024)
Salvin Dental Specialties, Inc. $111.14 1 $0 (2021)
PFIZER INC. $89.22 1 $0 (2018)
AstraZeneca Pharmaceuticals LP $49.12 3 $0 (2024)
AbbVie Inc. $43.01 2 $0 (2023)
Grifols USA, LLC $39.82 2 $0 (2019)
PORTOLA PHARMACEUTICALS, INC. $29.95 1 $0 (2019)
HOSPIRA, INC. $22.82 1 $0 (2017)

Payment History by Year

Year Amount Transactions Top Company
2024 $98.26 5 AstraZeneca Pharmaceuticals LP ($36.51)
2023 $64.29 3 Janssen Pharmaceuticals, Inc ($42.53)
2022 $71.70 4 Janssen Pharmaceuticals, Inc ($37.84)
2021 $236.14 2 Neurelis, Inc. ($125.00)
2020 $31.09 2 Paratek Pharmaceuticals, Inc. ($17.80)
2019 $60.13 3 PORTOLA PHARMACEUTICALS, INC. ($29.95)
2018 $326.72 8 Allergan Inc. ($215.76)
2017 $182.59 5 Allergan Inc. ($159.77)

All Payment Transactions

32 individual payment records from CMS Open Payments — Page 1 of 2

Date Company Product Nature Form Amount Type
11/19/2024 Octapharma USA, Inc. BALFAXAR (Biological) Food and Beverage In-kind items and services $17.28 General
Category: INTENSIVE CAREEMERGENCY
05/17/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $19.69 General
Category: Rare Disease
04/01/2024 Merck Sharp & Dohme LLC DIFICID (Drug), ZERBAXA Food and Beverage In-kind items and services $22.02 General
Category: INFECTIOUS DISEASE
03/07/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $16.82 General
Category: Rare Disease
01/22/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $22.45 General
Category: Cardiovascular & Metabolism
10/25/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $23.08 General
Category: Cardiovascular & Metabolism
08/16/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $19.45 General
Category: Cardiovascular & Metabolism
03/07/2023 AbbVie Inc. TEFLARO (Drug) Food and Beverage In-kind items and services $21.76 General
Category: ANTI-INFECTIVE
10/12/2022 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $12.61 General
Category: Rare Disease
08/24/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $22.86 General
Category: Cardiovascular & Metabolism
04/16/2022 ABBVIE INC. DALVANCE (Drug) Food and Beverage In-kind items and services $21.25 General
Category: ANTI-INFECTIVE
03/25/2022 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $14.98 General
Category: Cardiovascular & Metabolism
07/14/2021 Neurelis, Inc. VALTOCO (Drug) Food and Beverage In-kind items and services $125.00 General
Category: EPILEPSY
04/07/2021 Salvin Dental Specialties, Inc. Food and Beverage In-kind items and services $111.14 General
12/16/2020 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $13.29 General
Category: Cardiovascular & Metabolism
05/26/2020 Paratek Pharmaceuticals, Inc. NUZYRA (Drug) Food and Beverage In-kind items and services $17.80 General
Category: ANTIBIOTIC
12/09/2019 PORTOLA PHARMACEUTICALS, INC. ANDEXXA (Biological) Food and Beverage Cash or cash equivalent $29.95 General
Category: HEMATOLOGY/NEUROLOGY
02/13/2019 Avanir Pharmaceuticals, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $12.10 General
Category: pseudobulbar affect (PBA)
01/23/2019 Grifols USA, LLC HyperRAB SD (Biological) Food and Beverage In-kind items and services $18.08 General
Category: Immunology
08/31/2018 Allergan Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $9.78 General
Category: ANTI-INFECTIVE
08/02/2018 Grifols USA, LLC HyperRAB SD (Biological) Food and Beverage In-kind items and services $21.74 General
Category: Immunology
07/06/2018 Allergan Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $8.96 General
Category: ANTI-INFECTIVE
06/20/2018 Allergan Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $9.68 General
Category: ANTI-INFECTIVE
06/07/2018 Allergan Inc. AVYCAZ (Drug) Food and Beverage In-kind items and services $48.96 General
Category: ANTI-INFECTIVE
04/23/2018 Allergan Inc. DALVANCE (Drug) Food and Beverage In-kind items and services $128.60 General
Category: ANTI-INFECTIVE

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2022 2 37 39 $14,880 $5,310
2021 4 366 373 $107,760 $38,676
2020 4 269 273 $80,750 $28,708
Total Patients
672
Total Services
685
Medicare Billing
$72,694
Procedure Codes
10

All Medicare Procedures & Services

10 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99284 Emergency department visit for problem of high severity Facility 2022 26 28 $9,380 $3,379 36.0%
99285 Emergency department visit for life threatening or functioning severity Facility 2022 11 11 $5,500 $1,931 35.1%
99284 Emergency department visit, problem of high severity Facility 2021 195 201 $65,100 $23,532 36.1%
99285 Emergency department visit, problem with significant threat to life or function Facility 2021 44 44 $20,975 $7,657 36.5%
99283 Emergency department visit, moderately severe problem Facility 2021 103 104 $20,605 $7,328 35.6%
93042 Interpretation and report of electrical activity of heart using 1-3 leads Facility 2021 24 24 $1,080 $158.16 14.6%
99284 Emergency department visit, problem of high severity Facility 2020 164 167 $53,440 $19,453 36.4%
99285 Emergency department visit, problem with significant threat to life or function Facility 2020 33 34 $15,810 $5,656 35.8%
99283 Emergency department visit, moderately severe problem Facility 2020 59 59 $10,915 $3,512 32.2%
93042 Interpretation and report of electrical activity of heart using 1-3 leads Facility 2020 13 13 $585.00 $87.72 15.0%

About Dr. Lawrence Schiff, MD

Dr. Lawrence Schiff, MD is a Emergency Medicine healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1326075185.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Schiff, MD has received a total of $1,071 in payments from pharmaceutical and medical device companies, with $98.26 received in 2024. These payments were reported across 32 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,071).

As a Medicare-enrolled provider, Schiff has provided services to 672 Medicare beneficiaries, totaling 685 services with total Medicare billing of $72,694. Data is available for 3 years (2020–2022), covering 10 distinct procedure/service records.

Practice Information

  • Specialty Emergency Medicine
  • Location Stony Brook, NY
  • Active Since 06/27/2006
  • Last Updated 11/20/2018
  • Taxonomy Code 207P00000X
  • Entity Type Individual
  • NPI Number 1326075185

Products in Payments

  • DALVANCE (Drug) $347.82
  • VALTOCO (Drug) $125.00
  • XARELTO (Drug) $116.11
  • ELIQUIS (Drug) $89.22
  • ANDEXXA (Biological) $79.07
  • AVYCAZ (Drug) $48.96
  • HyperRAB SD (Biological) $39.82
  • THROMBIN (Drug) $22.82
  • DIFICID (Drug) $22.02
  • TEFLARO (Drug) $21.76
  • NUZYRA (Drug) $17.80
  • BALFAXAR (Biological) $17.28
  • NUEDEXTA (Drug) $12.10

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Emergency Medicine Doctors in Stony Brook